Arrowroot Family Office’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Buy |
+11,337
| New | +$1.43M | 0.64% | 41 |
|
|
2024
Q4 | $1.51M | Buy |
11,395
+4,354
| +62% | +$576K | 0.78% | 32 |
|
|
2024
Q3 | $1.03M | Buy |
7,041
+1,921
| +38% | +$280K | 0.6% | 44 |
|
|
2024
Q2 | $703K | Sell |
5,120
-102
| -2% | -$14K | 0.45% | 57 |
|
|
2024
Q1 | $717K | Sell |
5,222
-54
| -1% | -$7.41K | 0.46% | 57 |
|
|
2023
Q4 | $717K | Sell |
5,276
-1,459
| -22% | -$198K | 0.51% | 53 |
|
|
2023
Q3 | $824K | Buy |
6,735
+756
| +13% | +$92.5K | 0.65% | 47 |
|
|
2023
Q2 | $759K | Buy |
5,979
+2,414
| +68% | +$306K | 0.57% | 50 |
|
|
2023
Q1 | $460K | Buy |
+3,565
| New | +$460K | 0.39% | 65 |
|